New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.
Navigation
Daily News
- SEIU’s civil lawsuit against former local union staff and elected leaders: Trial set for Monday
- Evaluating all Medicare plan options can help people with disabilities reduce healthcare costs
- Deep Brain Stimulation Stops Seizures
- FDA Approves First Totally Implanted Hearing System
- Study Identifies Factors Associated With Early Detection Of Melanoma
Translator
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||
| By N2H | |||||||||